2024
Food Insecurity and Hypoglycemia among Older Patients with Type 2 Diabetes Treated with Insulin or Sulfonylureas: The Diabetes & Aging Study
Karter A, Parker M, Huang E, Seligman H, Moffet H, Ralston J, Liu J, Gilliam L, Laiteerapong N, Grant R, Lipska K. Food Insecurity and Hypoglycemia among Older Patients with Type 2 Diabetes Treated with Insulin or Sulfonylureas: The Diabetes & Aging Study. Journal Of General Internal Medicine 2024, 39: 2400-2406. PMID: 38767746, PMCID: PMC11436613, DOI: 10.1007/s11606-024-08801-y.Peer-Reviewed Original ResearchType 2 diabetes treated with insulinOlder patientsSevere hypoglycemiaFood insecurityAssociated with severe hypoglycemiaCharlson comorbidity scoreFood insecurity questionsCross-sectional studyComorbidity scoreSelf-reported reasonsMissed mealsHigh riskRisk factorsPatientsHypoglycemiaResultsFood insecurityFinancial strainDiabetesPrevention effortsAging StudySulfonylureaMedicationInsulinAgeRisk
2023
The Growing Role of Technology in the Care of Older Adults With Diabetes.
Huang E, Sinclair A, Conlin P, Cukierman-Yaffe T, Hirsch I, Huisingh-Scheetz M, Kahkoska A, Laffel L, Lee A, Lee S, Lipska K, Meneilly G, Pandya N, Peek M, Peters A, Pratley R, Sherifali D, Toschi E, Umpierrez G, Weinstock R, Munshi M. The Growing Role of Technology in the Care of Older Adults With Diabetes. Diabetes Care 2023, 46: 1455-1463. PMID: 37471606, PMCID: PMC10369127, DOI: 10.2337/dci23-0021.Peer-Reviewed Original ResearchConceptsOlder adultsAreas of careHealth care servicesDiabetes careContinuous glucose monitorEvidence-based technologiesDiabetes managementCare prioritiesClinical experienceClinical heterogeneityCare servicesDiabetesInsulin pumpCareScientific evidenceAdultsGlucose monitorDistinct subpopulationsCurrent knowledgeMajor barrierImportant populationPotential promiseCaregiversSevere hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging Study
Moffet H, Huang E, Liu J, Parker M, Lipska K, Laiteerapong N, Grant R, Lee A, Karter A. Severe hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging Study. Diabetes Epidemiology And Management 2023, 12: 100162. PMID: 37920602, PMCID: PMC10621321, DOI: 10.1016/j.deman.2023.100162.Peer-Reviewed Original ResearchSevere hypoglycemiaOlder adultsRisk of fallsCare-seeking behaviorLife-threatening eventsED visitsInpatient recordsPrevalence ratiosHypoglycemiaGreater prevalenceAge 65Clinical documentationDiabetesSample adultsAging StudyAdultsSurvey respondentsFallHospitalizationOutpatientsResearch designPrevalenceVisitsMonthsSeverity1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study
HAIDER S, PARKER M, HUANG E, GRANT R, MOFFET H, LAITEERAPONG N, LIU J, LIPSKA K, KARTER A. 1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study. Diabetes 2023, 72 DOI: 10.2337/db23-1217-p.Peer-Reviewed Original ResearchType 2 diabetesOlder patientsKaiser Permanente Northern CaliforniaDe-intensify treatmentDuration of diabetesGlucose-lowering medicationsNumber of medicationsProportion of patientsClinical guideline recommendationsHealth status factorsPoor health statusCross-sectional analysisInsulin useComplex regimensLess medicationGuideline recommendationsPatients' willingnessAbbVie Inc.Side effectsDiabetesPatient experiencePatientsHealth statusHypoglycemia historyMedications719-P: Feasibility and Acceptability of the Quality of Life, Burden of Treatment, Safety, and Avoidance of Future Events Agenda Setting Kit (QBSAFE ASK)
HAIDER S, GONZALEZ LOPEZ C, CLARK J, GRAVHOLT D, BRESLIN M, BOEHMER K, HARTASANCHEZ S, SANCHEZ B, MONTORI V, LIPSKA K. 719-P: Feasibility and Acceptability of the Quality of Life, Burden of Treatment, Safety, and Avoidance of Future Events Agenda Setting Kit (QBSAFE ASK). Diabetes 2023, 72 DOI: 10.2337/db23-719-p.Peer-Reviewed Original ResearchSingle-arm intervention studyStudy proceduresRoutine clinic visitsBurden of treatmentDiabetes-related topicsQuality of lifeClinic visitsMost patientsDiabetes carePatient goalsClinical careClinician responsesPatientsParticipant enrollmentIntervention studiesCliniciansAcceptability surveyCommon beingNational InstituteConversation CardsCareTreatmentEnrollmentAcceptabilityDiabetesDevelopment and Validation of the Life Expectancy Estimator for Older Adults with Diabetes (LEAD): the Diabetes and Aging Study
Karter A, Parker M, Moffet H, Lipska K, Laiteerapong N, Grant R, Lee C, Huang E. Development and Validation of the Life Expectancy Estimator for Older Adults with Diabetes (LEAD): the Diabetes and Aging Study. Journal Of General Internal Medicine 2023, 38: 2860-2869. PMID: 37254010, PMCID: PMC10228886, DOI: 10.1007/s11606-023-08219-y.Peer-Reviewed Original ResearchOlder adultsLife expectancyKaiser Permanente Northern CaliforniaRisk score toolLimited life expectancyClinical trial inclusionMortality prediction modelElectronic health recordsOlder patientsPatient characteristicsRetrospective cohortTrial inclusionAdvanced careCancer screeningClinical trialsTreatment goalsDiabetesSurvival analysisSurvival curvesLife expectancy modelCohortVital signsAging StudyHealth recordsKey ResultsIn
2022
Navigating barriers to affording and obtaining insulin and diabetes supplies
Wilcox A, Lipska K, Weinzimer S, Gujral J, Arakaki A, Kerandi L, Nally L. Navigating barriers to affording and obtaining insulin and diabetes supplies. Journal Of Diabetes 2022, 15: 71-75. PMID: 36562281, PMCID: PMC9870729, DOI: 10.1111/1753-0407.13344.Peer-Reviewed Original Research
2020
379-P: Glucagon Use by U.S. Adults with Type 1 and Type 2 Diabetes
KAHN P, LIU S, MCCOY R, GABBAY R, LIPSKA K. 379-P: Glucagon Use by U.S. Adults with Type 1 and Type 2 Diabetes. Diabetes 2020, 69 DOI: 10.2337/db20-379-p.Peer-Reviewed Original ResearchType 2 diabetesHigh-risk patientsType 1Diabetes patientsGlucagon useType 1 diabetes patientsAmerican Diabetes AssociationType 1 diabetesMedicare Advantage enrolleesPoor discriminative performanceGlucagon prescriptionsPrior hypoglycemiaRisk patientsDiabetes AssociationPrescribing practicesEndocrinology careMultivariable modelAdministrative claimsHigh riskPatientsType 2DiabetesModel AUCU.S. adultsGlucagonSCREENING FOR NEWLY DIAGNOSED DIABETES IN YOUNG ADULTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION-RESULTS FROM THE VIRGO (VARIATION IN RECOVERY ROLE OF GENDER ON OUTCOMES OF YOUNG ACUTE MYOCARDIAL INFARCTION PATIENTS) STUDY
Ding Q, Spatz E, Lipska K, Lin H, Spertus J, Dreyer R, Whittemore R, Funk M, Bueno H, Krumholz H. SCREENING FOR NEWLY DIAGNOSED DIABETES IN YOUNG ADULTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION-RESULTS FROM THE VIRGO (VARIATION IN RECOVERY ROLE OF GENDER ON OUTCOMES OF YOUNG ACUTE MYOCARDIAL INFARCTION PATIENTS) STUDY. Journal Of The American College Of Cardiology 2020, 75: 1918. DOI: 10.1016/s0735-1097(20)32545-6.Peer-Reviewed Original Research
2019
379-P: Changes in Diabetes Management after a Hospital Visit for Severe Hypoglycemia
VIJAYAKUMAR P, LIU S, KAHN P, MCCOY R, KARTER A, LIPSKA K. 379-P: Changes in Diabetes Management after a Hospital Visit for Severe Hypoglycemia. Diabetes 2019, 68 DOI: 10.2337/db19-379-p.Peer-Reviewed Original ResearchSevere hypoglycemic eventsType 2 diabetesDiabetes managementSevere hypoglycemiaHypoglycemic eventsNational InstituteGlucose-lowering medicationsGlucose-lowering therapyProportion of patientsThird of patientsEmergency department visitsPhysician office visitsContinuous glucose monitor useBaseline HbA1cED visitsDepartment visitsHospital admissionKidney diseaseOffice visitsMean ageHospital visitsClinical guidelinesMedication fillsHypoglycemiaDiabetes1249-P: Development and Validation of a Measure for Appropriateness of Glucose-Lowering Therapy
MCCOY R, LIPSKA K, HOUTEN H, SHAH N. 1249-P: Development and Validation of a Measure for Appropriateness of Glucose-Lowering Therapy. Diabetes 2019, 68 DOI: 10.2337/db19-1249-p.Peer-Reviewed Original ResearchGlucose lowering therapiesOptimal therapeutic regimensGlucose lowering medicationsDiabetes quality indicatorsNational InstituteMedicare Advantage enrolleesPatient-centered approachHigh-complexity patientsPerson/yearComorbidity burdenHospitalization visitsTreatment burdenHypoglycemia riskKidney diseaseTherapeutic regimensNational cohortNumber/typeClinical complexityPatientsMedicaid ServicesOptumLabsDiabetesTherapyVisitsAmerican Association1607-P: Prevalence and Correlates of Potential Glycemic Overtreatment and Undertreatment among U.S. Adults with Diabetes
MCCOY R, LIPSKA K, HOUTEN H, SHAH N. 1607-P: Prevalence and Correlates of Potential Glycemic Overtreatment and Undertreatment among U.S. Adults with Diabetes. Diabetes 2019, 68 DOI: 10.2337/db19-1607-p.Peer-Reviewed Original ResearchType 1 diabetesClinical complexityRace/ethnicityMale sexYounger ageAsian race/ethnicityHispanic race/ethnicityGlucose-lowering medicationsPoor glycemic controlLong-term complicationsHigh clinical complexityNational InstituteMedicare Advantage enrolleesAdministrative claims datasetEndocrine managementPatient comorbiditiesGlycemic controlTreatment regimenStudy cohortKidney diseasePotential overtreatmentDiabetesFM managementOvertreatmentU.S. adults